Miller Steve

Average Profitability
36.11%
Insider Buys Quantity
3
Insider Buys Sum
$506,440.40
Insider Sells Quantity
9
Insider Sells Sum
$10.66M

Insider Activity of Miller Steve

According to the SEC Form 4 filings, Miller Steve, being in a position of

  1. Chief Op. & Scientific Officer at Catalyst Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 200000 shares for $4.15M,
    over all time since 2012-07-03, has bought 295866 shares for $506,440, and sold 728434 shares for $10.66M.

The largest purchase of all time was on 2014-06-04 and amounted to 200000 shares of Catalyst Pharmaceuticals, Inc. for $433,980.

The largest sale of all time was on 2024-08-20 and amounted to 150000 shares of Catalyst Pharmaceuticals, Inc. for $3.05M.

Biography of Miller Steve

No biography is available at this moment.

2024-12-10SaleCatalyst Pharmaceuticals, Inc.
CPRX
Chief Op. & Scientific Officer
50,000
0.0417%
$21.93$1.1M-2.31%
2024-08-20SaleCatalyst Pharmaceuticals, Inc.
CPRX
Chief Op. & Scientific Officer
150,000
0.1243%
$20.35$3.05M+2.15%
2023-12-05SaleCatalyst Pharmaceuticals, Inc.
CPRX
Chief Op. & Scientific Officer
40,000
0.0377%
$14.24$569,600+14.23%
2022-11-23SaleCatalyst Pharmaceuticals, Inc.
CPRX
Chief Operating Officer
20,000
0.0195%
$17.34$346,740-16.38%
2022-11-21SaleCatalyst Pharmaceuticals, Inc.
CPRX
Chief Operating Officer
80,000
0.0751%
$15.28$1.22M-7.87%
2022-09-13SaleCatalyst Pharmaceuticals, Inc.
CPRX
Chief Operating Officer
107,933
0.1154%
$16.90$1.82M-2.91%
2022-08-18SaleCatalyst Pharmaceuticals, Inc.
CPRX
Chief Operating Officer
118,575
0.1124%
$13.56$1.61M+8.38%
2021-08-25SaleCatalyst Pharmaceuticals, Inc.
CPRX
Chief Operating Officer
80,000
0.0781%
$5.56$444,640+27.26%
2021-08-13SaleCatalyst Pharmaceuticals, Inc.
CPRX
Chief Operating Officer
81,926
0.08%
$6.09$498,831+15.23%
2016-01-11PurchaseCatalyst Pharmaceuticals, Inc.
CPRX
Chief Operating Officer
15,866
0.0183%
$1.80$28,559-42.02%
2014-06-04PurchaseCatalyst Pharmaceuticals, Inc.
CPRX
Chief Operating Officer
200,000
0.3036%
$2.17$433,980+36.11%
2012-07-03PurchaseCatalyst Pharmaceuticals, Inc.
CPRX
Chief Operating Officer
80,000
0.253%
$0.55$43,902+53.7%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.